Clinical Trials
12 trialsNCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT02352883 2025-12-19
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT01082211 2022-06-21
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00103181 2022-04-14
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
NSABP Foundation Inc
Phase NA Completed
NCT00058058 2019-07-16
ACRIN-6667
American College of Radiology Imaging Network
Phase NA Completed
NCT00053898 2018-09-20
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NSABP Foundation Inc
Phase 3 Completed
NCT01097278 2017-11-24
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
SWOG Cancer Research Network
Phase NA Completed
NCT01132560 2017-05-17
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Eastern Cooperative Oncology Group
Completed
NCT00967239 2015-05-08
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Unknown
NCT00324714 2012-11-29
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
ETOP IBCSG Partners Foundation
Phase 3 Withdrawn
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed